LLY $121.53 0.17 (0.1%)

    LLY Profile

    LLY trades on the NYSE.

    MEMBERSHIP
    S&P 500
    SECTOR
    Health Care
    MARKET CAPITALIZATION

    $117 Billion

    Large-Cap
    TWITTER

    LillyPad

    Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.

    LLY Earnings

    EPS

    1.37

    P/E

    40.60

    Q3 Earnings for Jul, Aug & Sep

    Wed, Oct 23, 2019

    Since Earnings Report

    LLY +10.6%

    Q4 Earnings for Oct, Nov & Dec

    Thu, Jan 30, 2020

    LLY Dividend

    Dividend Yield

    2.12%

    Dividend Rate

    $2.58

    Ex-Dividend Date

    Thu, Nov 14, 2019

    Dividend Pay Date

    Tue, Dec 10, 2019

    Dividend Frequency

    Quarterly

    Dividend Payments

    1,904 Payments

    LLY Charts

    52WL $101.36
    52WH $132.13
    All-Time $132.13


    LLY Industry Competitors


    BIOTECH & PHARMA
    Johnson & Johnson
    Merck
    Pfizer
    Bristol-Myers Squibb
    Amgen
    Novo Nordisk A/S
    AbbVie
    Sanofi SA (ADR)
    Gilead Sciences
    Celgene



    Symbol MC DY Price Day YTD
    LLY $116.68 2.12% $121.53 -0.1% 5.8%






        TOP    




    info@symbolsurfing.com


    Symbol Surfing

    ©2019 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy